Solid Tumor

The Archer® FusionPlex Solid Tumor panel is a targeted next-generation sequencing (NGS) product to simultaneously detect and identify fusions and other mutations associated with over 50 genes linked to various carcinomas. This panel uses Archer’s proprietary Anchored Multiplex PCR (AMP™)-based enrichment to detect all fusions associated with the genes in a single sequencing product, even without prior knowledge of fusion partners or breakpoints.

Thank You

Comprehensive Fusion Detection

AMP chemistry utilizes open-ended targeted amplification to identify gene fusions whether or not the fusion partner is known.

Splice Variants

Detect cancer-associated isoforms and alternative splicing events.

Low Input

Purpose-built for wide sample type compatibility, including low-input and degraded samples such as FFPE tissue.

Customization

Create from scratch or modify any panel to keep up with the pace of discovery.

Properties

Specifications

Gene Targets

53 Input Nucleic Acid Required*

≤10ng

Unique Molecular On-Target%

>92%

Hands-on Time

2.5 hours

Total Time

9 hours

Platform

Illumina® and Ion Torrent™

Sample Types

Fresh frozen and FFPE

Input recommendations for FFPE samples vary depending on Archer PreSeq® RNA QC score; 50ng input recommended in absence of PreSeq screening

LEGEND

SNV/Indel
Fusion, splicing or exon-skipping

Product Information

ILLUMINA®

ION TORRENT™

Archer® Analysis

Contact US

Need to modify your panel?

Add any of our wet lab-validated designs to this panel with Archer Assay Designer to build an assay that fits your exact requirements.

Learn More

Ready to Start?
Get A Quote

For Research Use Only. Not for use in diagnostic procedures.

Ready to Start? Request Demo Data